Cooley, Latham Lead $360M ScPharmaceuticals Acquisition
Cooley LLP-advised biopharmaceutical company MannKind on Monday unveiled plans to buy scPharmaceuticals, led by Latham & Watkins LLP, for up to $360 million....To view the full article, register now.
Already a subscriber? Click here to view full article